Professor Carmine Savoia
- Visiting Professor (School of Cardiovascular & Metabolic Health)
The University of Glasgow uses cookies for analytics. Find out more about our Privacy policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.
Analytical cookies help us improve our website. We use Google Analytics. All data is anonymised.
Hotjar and Clarity help us to understand our users’ behaviour by visually representing their clicks, taps and scrolling. All data is anonymised.
Neves, K. B. , Rios, F. J. , Van Der Mey, L., Alves-Lopes, R. , Cameron, A. C., Volpe, M., Montezano, A. C., Savoia, C. and Touyz, R. M. (2018) VEGFR (vascular endothelial growth factor receptor) inhibition induces cardiovascular damage via redox-sensitive processes. Hypertension, 71(4), pp. 638-647. (doi: 10.1161/HYPERTENSIONAHA.117.10490) (PMID:29483228)
Savoia, C. and Touyz, R. (2017) Hypertension, diabetes mellitus, and excess cardiovascular risk importance of baseline systolic blood pressure. Hypertension, 70(5), pp. 882-883. (doi: 10.1161/HYPERTENSIONAHA.117.09764) (PMID:28847887)
Savoia, C., Volpe, M., Grassi, G., Borghi, C., Rosei, E. A. and Touyz, R. M. (2017) Personalized medicine—a modern approach for the diagnosis and management of hypertension. Clinical Science, 131(22), pp. 2671-2685. (doi: 10.1042/CS20160407) (PMID:29109301) (PMCID:PMC5736921)
Callera, G. E., Antunes, T. T., He, Y., Montezano, A. C., Yogi, A., Savoia, C. and Touyz, R. M. (2016) c-Src inhibition improves cardiovascular function but not remodeling or fibrosis in Ang II-induced hypertension. Hypertension, 68(5), pp. 1179-1190. (doi: 10.1161/HYPERTENSIONAHA.116.07699) (PMID:27620391)
Touyz, R. M. , Montezano, A. C., Rios, F. J. and Savoia, C. (2014) Reply to letter by McIntyre et al. Canadian Journal of Cardiology, 30(12), 1733.e3. (doi: 10.1016/j.cjca.2014.10.004)
Small, H. Y., Montezano, A. C., Rios, F. J. , Savoia, C. and Touyz, R. M. (2014) Hypertension due to antiangiogenic cancer therapy with vascular endothelial growth factor inhibitors: understanding and managing a new syndrome. Canadian Journal of Cardiology, 30(5), pp. 534-543. (doi: 10.1016/j.cjca.2014.02.011)
Neves, K. B. , Rios, F. J. , Van Der Mey, L., Alves-Lopes, R. , Cameron, A. C., Volpe, M., Montezano, A. C., Savoia, C. and Touyz, R. M. (2018) VEGFR (vascular endothelial growth factor receptor) inhibition induces cardiovascular damage via redox-sensitive processes. Hypertension, 71(4), pp. 638-647. (doi: 10.1161/HYPERTENSIONAHA.117.10490) (PMID:29483228)
Savoia, C. and Touyz, R. (2017) Hypertension, diabetes mellitus, and excess cardiovascular risk importance of baseline systolic blood pressure. Hypertension, 70(5), pp. 882-883. (doi: 10.1161/HYPERTENSIONAHA.117.09764) (PMID:28847887)
Savoia, C., Volpe, M., Grassi, G., Borghi, C., Rosei, E. A. and Touyz, R. M. (2017) Personalized medicine—a modern approach for the diagnosis and management of hypertension. Clinical Science, 131(22), pp. 2671-2685. (doi: 10.1042/CS20160407) (PMID:29109301) (PMCID:PMC5736921)
Callera, G. E., Antunes, T. T., He, Y., Montezano, A. C., Yogi, A., Savoia, C. and Touyz, R. M. (2016) c-Src inhibition improves cardiovascular function but not remodeling or fibrosis in Ang II-induced hypertension. Hypertension, 68(5), pp. 1179-1190. (doi: 10.1161/HYPERTENSIONAHA.116.07699) (PMID:27620391)
Touyz, R. M. , Montezano, A. C., Rios, F. J. and Savoia, C. (2014) Reply to letter by McIntyre et al. Canadian Journal of Cardiology, 30(12), 1733.e3. (doi: 10.1016/j.cjca.2014.10.004)
Small, H. Y., Montezano, A. C., Rios, F. J. , Savoia, C. and Touyz, R. M. (2014) Hypertension due to antiangiogenic cancer therapy with vascular endothelial growth factor inhibitors: understanding and managing a new syndrome. Canadian Journal of Cardiology, 30(5), pp. 534-543. (doi: 10.1016/j.cjca.2014.02.011)